Boston Scientific Co. (NYSE:BSX) Given Consensus Recommendation of “Buy” by Brokerages
Boston Scientific Co. (NYSE:BSX – Get Free Report) has been given an average recommendation of “Buy” by the twenty-three ...
If You Invested $1000 in Boston Scientific a Decade Ago, This is How Much It'd Be Worth Now
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DOJoPAWP.js ...
manilatimes20d
Cardiovascular Devices Market to Hit US$110.39 Billion by 2029 with 7.3% CAGR | MarketsandMarkets™.
The global cardiovascular devices market, valued at US$72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, ...
Boston Scientific (NYSE:BSX) Price Target Raised to $115.00
Boston Scientific (NYSE:BSX – Free Report) had its price objective raised by Piper Sandler from $95.00 to $115.00 in a ...
RenovoRx: From Clinical Promise To Commercial Reality And Trading At A Significant Discount
RenovoRx's innovative RenovoCath and TAMP platform show promising clinical data. Click here to read why RNXT stock presents ...
Seeking Alpha4d
BSX Boston Scientific Corporation
Boston Scientific Corporation develops ... guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber ...
Healio26d
The year in thrombosis, CAD: New PCI populations and DAPT strategies
Next, Bhatt discussed the AGENT IDE trial, which compared a paclitaxel-coated balloon (Agent, Boston Scientific) with an uncoated balloon for treatment of coronary in-stent restenosis. The results ...
Editorial Roundup: United States
The prevailing dislike for imports among America’s political class has an old and bipartisan pedigree. President Donald Trump ...
A Less Brutal Alternative to IVF
Many people who continue with IVF feel that, if they want a child, they have no other choice. “Right now our treatment options are pretty binary,” Pietro Bortoletto, the director of reproductive ...